Monthly Archives: April 2020

It’s Okay to Breakdown

I’ve been ruminating on this post for a few days, as I struggled to decide what to blog about this week. This is a tough and heavy topic, but I finally settled on discussing it because it *is* so important, particularly at this moment in time when so many people are struggling and vulnerable. Why add my voice when so many others have already provided great resources and their own stories? Well, I hope I have something of my own to add, because of my own struggles with depression for the past twenty-plus years and because I think that we can never talk about it enough to break the stigma and ensure that people get the help that they need.  (Please note, **trigger warning** for this entire post). 

Read full article

U.S. DOL Provides Guidance on Expanded Unemployment Compensation Benefits Under CARES: UIPL 15-20, 16-20, and 17-20

The U.S. Department of Labor (DOL) recently published three Unemployment Insurance Program Letters (UIPLs) offering guidance on the administration of separate sections of the Coronavirus Aid, Relief, and Economic Security Act, or the “CARES Act,” that provide for expanded unemployment insurance benefits. While the UIPLs are directed to state agencies, the UIPLs contain helpful information for employers.

Read full article
ILN Today Post

ILN Labor Group Paper – Paid Leave

Twenty ILN member firms collaborated to answer the question, “Are employees entitled to paid leave due to Covid-19?” The following document addresses in summary form this issue in a number of jurisdictions.

Read full article
ILN Today Post

Key Considerations for Retailers in the Face of COVID-19

Retailers are facing unprecedented challenges in the face of the COVID-19 pandemic. While some companies, such as wholesalers of essential household items and groceries, are experiencing a surge in demand, others, especially those that rely on a brick-and-mortar presence, are suffering. Recent reports show that retail sales had plummeted in March 2020 to a degree never before seen. All retailers are forced to confront the “new normal,” in particular taking steps to attempt to shift all, or substantially all, of their business online. Read more…

Read full article

California Governor Mandates Supplemental Paid Sick Leave for Food Sector Workers at Companies with 500 or More Employees

On April 16, 2020, California Governor Gavin Newsom signed Executive Order N-51-20  (“Executive Order”), mandating supplemental paid sick leave for food sector workers at companies (i.e., “Hiring Entities”) with 500 or more employees. The Executive Order should help fill a gap for essential food sector workers left open under the federal Families First Coronavirus Relief Act (“FFCRA”) (previously discussed here).

The Executive Order is effective immediately and remains effective during any statewide stay-at-home order. Like the recently enacted Supplemental paid sick leave under the Executive Order ordinance passed by the Los Angeles City Council larger employers in the food sector must quickly become familiar with this order.

Read full article
ILN Today Post

Extension for holding Annual General Meeting

According to Section 96 of the Companies Act, 2013 (“Act”), companies are to hold their annual general meeting (“AGM”) within a period of 6 (six) months from the date of closing of the financial year and companies which are to hold their first AGM shall be held within a period of 9 (nine) months from the date of closing of the first financial year of that company.

Read full article

Compulsory Licensing in Russia in the view of COVID-19

Nowadays the sphere of healthcare is becoming one of the mostly discussed because of a mass spread of the coronavirus pandemic (also COVID-19). Confirmed cases of COVID-19 around the world have passed more than a 2.4 million. As the disease is continuing to surge the World Health Organization is warning that there are no specific vaccines or treatments for COVID-19 as for today. However, there are many ongoing clinical trials evaluating potential treatments and developing drugs conducted by different laboratories in developed countries.

Read full article
ILN Today Post

Safeguarding against Opportunistic Acquisitions – Restriction on FDI from China

In a significant change to the Foreign Direct Investment Policy 2017 (“FDI Policy”), the Department for Promotion of Industry and Internal Trade has issued Press Note No. 3 (2020 Series) dated April 17, 2020 (“Press Note 3”), wherein it has imposed certain restrictions for receiving FDI from neighbouring countries. According to the Press Note 3, any entity of a country which shares its land borders with India (i.e. China, Nepal, Bhutan, Bangladesh, Myanmar, Pakistan and Afghanistan) (“Specified Country”) or where the beneficial owner of any investment in India is based in such country or is citizen of such a country, will now require prior approval from the Government for its direct investment in India. Additionally, any transfer of ownership (whether existing or future) of an entity in India resulting in the beneficial ownership being situated in a Specified Country will also require prior Government approval. Changes proposed vide Press Note 3 will have statutory effect upon amendment of the Foreign Exchange Management (Non-Debt Instruments) Rules, 2019 (“NDI Rules”).

Read full article
ILN Today Post

This trade bulletin summarizes important developments affecting international trade.

USMCA Interim Implementing Instructions
COVID-19 or not the United States Mexico Canada agreement’s (USMCA) implementation date is fast approaching. The U.S. Customs and Border Protection has issued Interim Implementing Instructions to provide early guidance on the new requirements under the USMCA, including on claiming USMCA preferential treatment for goods. The Final Implementing Instructions will be released prior to the date the USMCA enters into force.

For the Interim Implementing Instructions click here. Don’t hesitate to contact us with questions.

Read full article

FDA Authorizes the First Home Collection of Specimens to be Tested for COVID-19

As an update to our prior blog post, on April 20, 2020 FDA announced the authorization of the first COVID-19 test for home collection of specimens. This announcement, made via the Agency’s FAQs on Diagnostic Testing for SARS-CoV-2 webpage, comes after weeks of FDA reporting that it has been working closely with manufacturers on such a test during the weekly Virtual Town Hall Meetings hosted by the Center for Devices and Radiological Health. FDA clarifies that the test is only authorized for home collection of specimens to be sent back to a laboratory for processing. FDA still has not authorized a COVID-19 test “to be completely used and processed at home.”

Read full article